FLT3 ligand in acute myeloid leukemia: a simple test with deep implications-Reference-Cited by-同舟云学术

FLT3 ligand in acute myeloid leukemia: a simple test with deep implications

Published:2020-10-20 Issue:2 Volume:62 Page:264-270
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Peterlin Pierre¹²,Chevallier Patrice¹²,Knapper Steven³,Collin Matthew⁴

Affiliation:

1. Hematology Clinic, CHU de Nantes, Nantes, France

2. CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France

3. Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK

4. Newcastle University Translational and Clinical Research Institute and NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle Upon Tyne, UK

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1834091

Reference50 articles.

1. Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells

2. The Cytokine Flt3-Ligand in Normal and Malignant Hematopoiesis

3. Biochemical and genetic characterization of multiple splice variants of the Flt3 ligand

4. Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia

5. Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia;Expert Review of Hematology;2024-05-20

2. Role of Novel Inflammatory Factors in Central Retinal Vein Occlusion with Macular Edema;Medicina;2023-12-19

3. Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models;International Journal of Molecular Sciences;2023-04-21

4. The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy;Cancers;2022-08-09

5. A review of FLT3 inhibitors in acute myeloid leukemia;Blood Reviews;2022-03